investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Computational and Experimental RNA Nanobiology
Bruce Shapiro
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Patrick O'Donoghue
CRC Tier 2 - Protein modifications Signalling
All cancers but non-melanoma skin cancer
Jenny Hsu
A novel role for E2F4 as a transcriptional activator and a cell cycle driver
All cancers but non-melanoma skin cancer
Xiaoliang Sunney Xie
Whole Genome Amplification and Sequencing of Single Cancer Cells
All cancers but non-melanoma skin cancer
Benjamin Neel
The Gab/Par pathway in development and cancer
All cancers but non-melanoma skin cancer
Barbara Felber
Prevention of AIDS
All cancers but non-melanoma skin cancer
Jerry Pelletier
Targeting the DHX9 Helicase for Small Molecule Probe Discovery
All cancers but non-melanoma skin cancer
Yun-Xing Wang
SAXS Core
All cancers but non-melanoma skin cancer
Damien Garbett
Identification of mechanisms involved in coordinated group migration
All cancers but non-melanoma skin cancer
Chantal Guillemette
Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)
All cancers but non-melanoma skin cancer
